Skip to main content
Nutrition Journal logoLink to Nutrition Journal
. 2026 Jun 2;25:86. doi: 10.1186/s12937-026-01343-5

Curcumin supplementation during high-altitude exposure modulates body composition and its relationship with gut microbiota: a randomized controlled trial

Jilei Hu 1, Die Fan 1, Chunxiu Xiao 1, Chao Kang 1, Jiaojiao Shi 1, Yunming Li 2, Jie Liu 1, Lirong Shen 3, Ning Lin 1,4,✉
PMCID: PMC13455257  PMID: 42231385

Abstract

Background

Body composition is crucial for athletic performance and linked to the gut microbiota. Curcumin shows potential to promote muscle regeneration and modulate fat metabolism, but evidence from high-altitude populations remains scarce. This study aimed to evaluate the effects of curcumin on body composition at high altitudes, and explore potential role of gut microbiota.

Methods

A total of 102 male Han participants was randomized to curcumin (812 mg/d) or placebo groups for 1-week pre-acclimatization and 6-week high-altitude acclimatization. Body composition was assessed via bioelectrical impedance analysis and gut microbiota was analyzed through metagenomic sequencing.

Results

After high-altitude acclimatization, curcumin significantly reduced the percent body fat (PBF, P = 0.030). Soft lean mass (SLM), skeletal muscle mass (SMM) and fat free mass (FFM) were increased in both groups, but the curcumin group exhibited greater increases although without significant difference. Curcumin supplementation significantly attenuated the upper-limbs FFM and arm muscle circumference reduction (P < 0.05). The relative abundance of Eubacterium sp. CAG:180 was significantly negative with SLM and SMM (P < 0.05). Curcumin significantly increased the abundance of Bifidobacterium pseudocatenulatum, Eubacterium sp. CAG:274 and Eubacterium eligens (P < 0.01). Higher abundance of Eubacterium sp. CAG:274, Roseburia inulinivorans, and Bifidobacterium pseudocatenulatum were observed in high-skeletal muscle index participants. Lachnospira pectinoschiza, Clostridium leptum, and Eubacterium sp. CAG:274 were more abundant in low-PBF participants.

Conclusions

Curcumin supplementation might increase muscle mass gain and reduce PBF during high-altitude acclimatization that may correlate with changes in gut microbiota composition, and their causal association remains to be further verified.

Trial registration

Chinese Clinical Trail Registry, ChiCTR220005965. Registered on May 5, 2022.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12937-026-01343-5.

Keywords: Curcumin, Gut microbiome, Fat free mass, Body fat mass, Skeletal muscle mass

Introduction

Body composition represents an important aspect of physical fitness and has gained increasing attention in recent years. Exposure to high altitude might cause the body to adapt with negative energy and fluid balance that compromise body composition and physical performance. Systematic review and meta-analysis studies have reported significant reductions in body weight, body fat mass (BFM), fat free mass (FFM), and lean body mass (LBM) of individuals exposed to high altitude, and these components play distinct roles in the weight loss caused by the plateau environment [1, 2]. Furthermore, it has been observed at high altitude that the decline of FFM, total body water (TBW), and ECW might be related to the severity of acute mountain sickness (AMS), and fatigue was the AMS relevant symptom which was closely related to the decline of FFM, TBW, intracellular water (ICW) and extracellular water (ECW) [3]. In the healthy indigenous populations living on the Qinghai-Tibet Plateau, protein mass, bone mass, fat mass and body water values decrease with increasing altitude [4]. Additionally, exposure to high-altitude hypobaric environment can lead to serious loss of muscle mass, which results in skeletal muscle trophy. Muscle loss and decreased protein reserves likely contribute to the decreased physical performance and the increased infection rate and slow wound healing reported with chronic hypoxic exposure. Therefore, it is of great significance to investigate the changes of body composition and physiological and environmental factors associated with high-altitude exposure.

Body composition changes induced by high-altitude exposure are not only regulated by direct physiological adaptations to hypoxia but also potentially modulated by gut microbiota, a key factor involved in human metabolic and immune homeostasis. Notably, gut microbiota is also significantly influenced by altitude, although the dynamics of gut microbiota in relation to altitude remains undisclosed. The roles played by the gut microbiota in human health have been increasingly recognized, including the gut-muscle axis between the gut microbiome and skeletal muscles [5]. It has been found that the gut microbiota and its metabolites impact the muscles in various ways by influencing nutrient absorption, immune inflammation, and energy metabolism. Our previous study observed that curcumin supplementation modulated gut microbiota by increasing the abundance of butyrate-producing bacteria including Roseburia, Lachnospira, and Sellimonas to accelerate high-altitude acclimatization [6]. Gut butyrate is considered to attribute to an increase in LBM and/or FFM and a reduction in BFM [7]. In addition, butyrate derivative b-hydroxy-b methyl butyrate has been demonstrated that enhances the synthesis of muscle proteins, reduces the breakdown of muscle proteins and improves the stability of muscle membranes, resulting in improvement of muscle quality [8].

Given the close association between gut microbiota, body composition, and high-altitude adaptation, and the known regulatory effects of curcumin on gut microbiota, curcumin may further exert a protective role in mitigating high-altitude-induced adverse changes in body composition by modulating the gut-muscle axis. Previous studies have clearly shown that chronic hypobaric hypoxia induced muscle atrophy results in decreased physical performance at high altitude [9]. Prolonged and severe hypoxia menaces human function and survival, and also associated with profound loss of muscle mass which results into a debilitating critical illness of skeletal muscle atrophy [10]. Curcumin has a significant protective effect on relieving exercise fatigue and skeletal muscle injury [11, 12]. Curcuminoid degradants supplementation effectively promoted protein synthesis and inhibit degradation in muscle tissue by activating the PI3K/Akt/mTOR pathway, potentially through modulation of gut microbiota [13]. Recent clinical trials reported curcumin show significant effects on improve body composition by decreasing fat mass or inhibiting FFM loss [14]. Furthermore, curcumin administration significantly enhanced muscle mass under hypobaric hypoxia resulting in improved physical performance of the rats at high altitude [15]. Despite these promising findings, the specific mechanism by which curcumin regulates body composition in high-altitude environments, particularly its interplay with gut microbiota and the gut-muscle axis-remains unclear, and limited studies have directly investigated the effects of curcumin on body composition among populations exposed to high-altitude environments. In the present study, body composition and gut microbiota were evaluated from the plains to the plateau for male Han population, and the changes of them were assessed during high-altitude exposure. This study also investigated the potential role of gut microbiota on the changes of body composition induced by high-altitude exposure.

Participants and methods

Materials

Curcumin gummies and placebo were produced by Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd (Luohe, China). Test results of high-performance liquid chromatography according to our previous study showed that the curcumin gummies contained curcumin 1.16% [6].

Participant enrollment

This analysis is part of curcumin promotes high-altitude acclimatization discovery study that aims to identify and/or validate the effects of curcumin on acute/chronic mountain sickness and physical performance. The inclusion criteria are healthy Han Chinese males aged 18–45, born and have resided long-term in regions at altitudes less than 500 m. Exclusion criteria include any diagnosed acute, chronic or infectious diseases. The study was approved by the ethics committee of General Hospital of the Western Theater Command (No. 2021EC3-45), and registered on the Chinese Clinical Trials Registry (ChiCTR220005965). All the participants provided written informed consent.

A total of 102 eligible participants were randomly assigned to either placebo or curcumin group, with 12 withdrawals due to personal reasons. Ultimately, 44 participants in the curcumin group and 46 participants in the placebo group finished the trial. The curcumin group participants received curcumin 812 mg/d for 7 weeks (1 week before entering the plateau and 6 weeks on the plateau), and placebo group subjects took equivalent gardenia yellow gummies. Blood samples were collected at baseline (T0), 1st week on the plain (T1), and 6th week after entering plateau (T2). A comprehensive description of the study design and procedures is provided in the Supplementary Method.

Body composition and handgrip strength assessment

Body composition measurements were carried out at T0, T1, and T2. A multi-frequency bioelectrical impedance analyzer, InBody S10 Biospace device (Biospacte Co, Ltd, Korea/Model JMW140) was used for body composition measurements according to the manufacturer’s guidelines [16]. Primary outcomes included PBF, BFM (whole body, appendicular, trunk), skeletal muscle index (SMI), and FFM (whole body, appendicular, trunk). Body composition measurements at each time point were conducted for all participants on the same day between 7:00 and 9:00 a.m., after they were asked to empty their bladders and on an empty stomach. The participants stood upright while measured, with hands holding the electrodes and feet on the electrodes, wearing light clothing with pockets emptied, no metal objects and no shoes. Participants were asked to empty their bladder and maintain a standing position for five minutes prior to measurement to minimize potential influences on BIA values. All procedures were performed by the same two researchers, with one responsible for fitting the equipment on the participants and the other for operating the instruments.

Handgrip strength (HGS) was measured using a dynamometer (ANTA Sports Products Limited, Quanzhou, China) of the dominant hand. During testing, participants stood upright with feet shoulder-width apart. The tested arm hung naturally with elbow flexed at 90°, upper arm at 20°-30° to the trunk, and wrist in neutral position. They squeezed the dynamometer gradually to maximum force and held for 3 s, avoiding sudden exertion or Valsalva maneuver. All tests were performed on the participant’s self-reported dominant arm.

Gut microbiota analyses

Stool samples were collected from participants at T0 and T2. Participants were instructed to collect approximately 2 g of fresh faecal sample (mid-section of the bowel movement) avoiding contact with urine or toilet water. All samples were transported to the laboratory on dry ice within 2 h. Upon arrival at the laboratory, samples were aliquoted into 200 mg sub-samples for DNA extraction and metagenomic sequencing, and the remainder was stored at -80 °C. These sub-samples were submitted to Novogene Co., Ltd. (Beijing, China). The protocol included genomic DNA extraction, DNA random fragmentation, library preparations, Illumina Novaseq 6,000 platform sequencing, sequence assembly, bioinformatics analysis. After OTUs clustering and annotation, diversity analysis, community structure assessment, biomarker identification, and microbe-metabolite correlation analysis were performed at each taxonomic level.

Statistical analysis

All statistical analyses were analyzed with SPSS software (version 22.0, IBM, Chicago, IL, USA). Data are expressed as mean ± SEM, and statistical significance is defined as P < 0.05. The Shapiro-Wilk test was applied to determine the normality of the variable distribution for quantitative data. Differences between groups were compared analyzed by independent samples t-test or Wilcoxon rank sum test depending on the normality of the variable distribution, while differences within groups were evaluated by paired sample t-test or Wilcoxon paired signed-rank test. The changes in variables over time were evaluated by repeated measures ANOVA.

Results

Baseline data

A total of 102 participants began (n = 51 placebo group; n = 51 curcumin group) the interventions and were involved in the safety assessment (the full analysis set population). Ninety participants completed the 7-week intervention, and the per-protocol set population was used for efficacy assessment (n = 46 placebo group; n = 44 curcumin group). The baseline age, height, weight, and BMI of the curcumin group were statistically comparable to those of the placebo group, as detailed in our previous study [6]. No significant differences were observed between the two groups in other baseline characteristics including BFM, PBF, SLM, SMM, FFM, and HGS (Table 1).

Table 1.

Baseline characteristics of subjects

Curcumin (n = 51) Placebo (n = 51) P (between groups)
BFM (kg) 13.00 ± 0.48 12.23 ± 0.45 0.250
PBF (%) 18.23 ± 0.45 16.93 ± 0.51 0.060
Protein (kg ) 11.38 ± 0.17 11.78 ± 0.15 0.082
FFM (kg) 57.61 ± 0.89 59.53 ± 0.76 0.104
SLM (kg) 54.40 ± 0.83 56.22 ± 0.71 0.099
SMM (kg) 32.35 ± 0.53 33.54 ± 0.45 0.090
HGS (kg) 46.02 ± 1.00 46.28 ± 0.94 0.847

P (between groups), the differences between groups were compared by independent sample t−test

Abbreviations: BMI Body Mass Index, BFM Body Fat mass, PBF Percent Body Fat, Protein, estimated by BIA and calculated indirectly by lean body mass, water content, and mineral; FFM Free Fat Mass, SLM Soft Lean Mass, SMM Skeletal Muscle Mass, HGS Handgrip Strength

Effects of curcumin on body composition

Effects of curcumin on body composition parameters were presented in Table 2. No significant group × time interactions was observed. A significant group effect was observed in PBF (P = 0.030), while significant time effect was detected across multiple indices including body weight, BMI, protein, mineral, PBF, SLM, BMC, ICW, TBW, and BMR (P < 0.001). Furthermore, a greater decrease from T1 to T2 in curcumin group was observed in PBF when compared with placebo group (P = 0.032).

Table 2.

Effects of curcumin on body composition in subjects

Outcome Curcumin (n = 44) Placebo (n = 46) Changes comparison at T1
(vs. T0)
Changes comparison at T2
(vs. T1)
P (time×group)
T0 T1 T2 T0 T1 T2 Curcumin Placebo P Curcumin Placebo P
Weight (kg) 70.11 ± 7.96 70.88 ± 8.48 67.90 ± 7.57 71.27 ± 6.86 71.49 ± 6.94 69.28 ± 6.16 0.76 ± 0.22 0.23 ± 0.23 0.099 -2.98 ± 0.33 -2.22 ± 0.33 0.104 0.172*
BMI (kg/m2) 23.40 ± 2.08 23.57 ± 2.18 22.63 ± 1.98 23.11 ± 1.90 23.20 ± 2.03 22.47 ± 1.72 0.25 ± 0.07 0.08 ± 0.08 0.113 -0.99 ± 0.11 -0.72 ± 0.11 0.082 0.266*
Protein (kg) 11.25 ± 1.08 11.53 ± 1.08 11.96 ± 1.16 11.73 ± 1.09 11.98 ± 1.07 12.35 ± 1.08 0.29 ± 0.05 0.25 ± 0.05 0.584 0.43 ± 0.05 0.37 ± 0.04 0.386 0.423*
Mineral (kg) 3.85 ± 0.42 3.98 ± 0.44 4.31 ± 0.56 3.98 ± 0.42 4.13 ± 0.47 4.54 ± 0.56 0.13 ± 0.02 0.14 ± 0.02 0.797 0.33 ± 0.04 0.42 ± 0.03 0.080 0.423*
PBF (%) 18.55 ± 3.24 17.69 ± 3.71 11.63 ± 4.30 16.79 ± 3.68 15.57 ± 3.28 10.76 ± 3.86 -0.86 ± 0.27 -1.21 ± 0.20 0.301 -6.06 ± 0.44 -4.82 ± 0.37 0.032 0.071*#
SLM (kg) 53.79 ± 5.19 54.86 ± 5.17 56.25 ± 5.40 55.95 ± 5.11 56.86 ± 5.11 57.96 ± 5.11 1.07 ± 0.23 0.91 ± 0.21 0.599 1.39 ± 0.22 1.10 ± 0.22 0.350 0.398*
BMC (kg) 3.17 ± 0.35 3.28 ± 0.38 3.59 ± 0.49 3.28 ± 0.35 3.41 ± 0.40 3.81 ± 0.50 0.11 ± 0.02 0.13 ± 0.02 0.266 0.31 ± 0.03 0.40 ± 0.03 0.075 0.057*
ICW 26.03 ± 2.51 26.70 ± 2.50 27.70 ± 2.69 27.12 ± 2.49 27.69 ± 2.51 28.58 ± 2.53 0.67 ± 0.11 0.57 ± 0.10 0.488 1.00 ± 0.11 0.88 ± 0.10 0.439 0.398*
ECW 15.84 ± 1.58 15.92 ± 1.55 15.87 ± 1.56 16.40 ± 1.50 16.47 ± 1.48 16.29 ± 1.45 0.08 ± 0.08 0.08 ± 0.07 0.972 -0.55 ± 0.08 -0.18 ± 0.08 0.263 0.453*
TBW 41.87 ± 4.05 42.62 ± 4.02 43.57 ± 4.18 43.52 ± 3.98 44.17 ± 3.97 44.87 ± 3.95 0.75 ± 0.18 0.65 ± 0.16 0.662 0.95 ± 0.18 0.70 ± 0.17 0.325 0.408
BMR (kcal/d) 1600.50 ± 119.41 1625.84 ± 119.39 1662.55 ± 126.15 1649.44 ± 117.86 1672.00 ± 118.81 1704.41 ± 119.81 25.34 ± 5.22 22.57 ± 4.84 0.697 36.70 ± 5.13 32.41 ± 5.02 0.551 0.642*

P (time×group), interaction effect between group and time in repeated measures ANOVA; *P < 0.05, time effect is significant in the repeated measures ANOVA; #P < 0.05, group effect is significant in the repeated measures ANOVA. P values less than 0.05 are bold, indicating that these results are statistically significant. Protein, estimated by BIA and calculated indirectly by lean body mass, water content, and mineral

Effects of curcumin on muscle mass and HGS

Table 3 detailed the effects of curcumin on muscle mass and strength. Significant group × time interactions were observed for FMM-RA, FMM-LA, FMM-trunk, and AMC (P < 0.05). Significant group effect was noted for FMM-RL and FMM-LL (P < 0.05), and highly significant time effect was detected for SMI, FMM, FMM-RA, FMM-LA, FMM-RL, FMM-LL, FMM-trunk, AC, AMC, and HGS (P < 0.001). Greater changes from T0 to T1 in curcumin group were observed in FMM-RA (P = 0.036), FMM-LA (P = 0.003), FFM-Trunk (P = 0.003), AC (P = 0.002) and AMC (P = 0.040) when compared with placebo group. However, lower decrease from T1 to T2 in curcumin group were observed in FMM-LA (P = 0.047) and AMC (P = 0.038) when compared with placebo group. The increase trend of HGS from T1 to T2 was observed only in the curcumin group although without significant difference (P = 0.301).

Table 3.

Effects of curcumin on muscle mass and HGS in subjects

Outcome Curcumin (n = 44) Placebo (n = 46) Changes comparison at T1 (vs. T0) Changes comparison at T2 (vs. T1) P (time×group)
T0 T1 T2 T0 T1 T2 Curcumin Placebo P Curcumin Placebo P
SLM (kg) 53.79 ± 5.19 54.86 ± 5.17 56.25 ± 5.40 55.95 ± 5.11 56.86 ± 5.11 57.96 ± 5.11 2.05 ± 0.43 1.67 ± 0.39 0.505 2.55 ± 0.39 1.98 ± 0.39 0.309 0.072*
SMM (kg) 31.95 ± 3.27 32.82 ± 3.26 34.13 ± 3.49 33.38 ± 3.25 34.11 ± 3.28 35.27 ± 3.30 0.88 ± 0.14 0.74 ± 0.13 0.473 1.31 ± 0.14 1.16 ± 0.14 0.446 0.395*
SMI (kg/m2) 8.11 ± 0.56 8.22 ± 0.53 8.85 ± 0.61 8.28 ± 0.56 8.41 ± 0.57 8.99 ± 0.66 0.11 ± 0.21 0.13 ± 0.20 0.586 0.63 ± 0.05 0.58 ± 0.05 0.494 0.693*
FFM (kg) 56.96 ± 0.83 58.14 ± 0.83 59.84 ± 0.88 59.23 ± 0.80 60.27 ± 0.81 61.77 ± 0.82 1.18 ± 0.24 1.04 ± 0.22 0.692 1.70 ± 0.24 1.50 ± 0.23 0.537 0.628*
FFM-RA (kg) 3.04 ± 0.06 3.14 ± 0.06 2.66 ± 0.06 3.20 ± 0.05 3.24 ± 0.05 2.65 ± 0.05 0.10 ± 0.02 0.04 ± 0.02 0.036 -0.47 ± 0.05 -0.59 ± 0.04 0.072 0.011 *
FFM-LA (kg) 3.01 ± 0.06 3.12 ± 0.06 2.67 ± 0.06 3.19 ± 0.05 3.22 ± 0.05 2.64 ± 0.05 0.12 ± 0.02 0.03 ± 0.02 0.003 -0.46 ± 0.04 -0.58 ± 0.04 0.047 0.002 *
FFM-RL (kg) 9.19 ± 0.15 9.27 ± 0.15 10.73 ± 0.20 9.61 ± 0.15 9.77 ± 0.15 11.27 ± 0.19 0.09 ± 0.05 0.16 ± 0.04 0.204 1.45 ± 0.11 1.50 ± 0.10 0.782 0.567*#
FFM-LL (kg) 9.13 ± 0.15 9.21 ± 0.15 10.54 ± 0.19 9.58 ± 0.15 9.74 ± 0.15 11.21 ± 0.18 0.08 ± 0.04 0.16 ± 0.04 0.146 1.32 ± 0.11 1.47 ± 0.09 0.315 0.198*#
FFM-Trunk (kg) 24.49 ± 0.34 25.19 ± 0.34 22.71 ± 0.38 25.55 ± 0.31 25.82 ± 0.29 22.69 ± 0.32 0.70 ± 0.10 0.26 ± 0.10 0.003 -2.48 ± 0.27 -3.13 ± 0.23 0.068 0.005 *
AC (cm) 30.42 ± 1.73 30.80 ± 1.81 27.99 ± 2.16 30.54 ± 1.51 30.62 ± 1.60 27.46 ± 1.66 0.37 ± 0.06 0.08 ± 0.07 0.002 -2.81 ± 0.22 -3.15 ± 0.22 0.271 0.071*
AMC (cm) 27.64 ± 1.46 28.00 ± 1.43 25.57 ± 1.74 27.96 ± 1.21 28.12 ± 1.31 25.11 ± 1.40 0.36 ± 0.05 0.16 ± 0.08 0.040 -2.43 ± 0.19 -3.01 ± 0.20 0.038 0.009 *
HGS (kg) 45.43 ± 1.00 45.47 ± 1.03 46.10 ± 1.02 46.39 ± 0.98 47.57 ± 1.01 47.30 ± 0.99 0.04 ± 0.65 1.18 ± 0.64 0.217 0.63 ± 0.65 -0.27 ± 0.60 0.301 0.389

P (time×group), interaction effect between group and time in repeated measures ANOVA; *P < 0.05, time effect is significant in the repeated measures ANOVA; #P < 0.05, group effect is significant in the repeated measures ANOVA. P values less than 0.05 are bold, indicating that these results are statistically significant

Abbreviations: SMM Skeletal Muscle Mass, SMI Skeletal Muscle Index, SLM Soft Lean Mass, FFM Fat Free Mass, FMM−RA Fat Free Mass of Right Arm, FFM−LA Fat Free Mass of Left Arm, FFM−RL Fat Free Mass of Right Leg, FFM−LL Fat Free Mass of Left Leg, FFM−Trunk Fat Free Mass of Trunk, AC Arm Circumference, AMC Arm Muscle Circumference. HGS Handgrip Strength

Effects of curcumin on fat mass

The effects of curcumin on fat mass were summarized in Table 4. Significant group × time interactions were detected for BFM-RA (P = 0.011) and BFM-LA (P = 0.005). Significantly time effect was observed in BFM, BFM-RA, BFM-LA, BFM-RL, BFM-LL, BFM-trunk, and waist circumference (WC) (P < 0.001). Greater decrease from T1 to T2 in curcumin group were observed in BFM-RA (P = 0.007), BFM-LA (P = 0.004), and BFM-trunk (P = 0.043) when compared with placebo group.

Table 4.

Effects of curcumin on fat mass in subjects

Outcome Curcumin (n = 44) Placebo (n = 46) Changes comparison at T1 (vs. T0) Changes comparison at T2 (vs. T1) P (time×group)
T0 T1 T2 T0 T1 T2 Curcumin Placebo P Curcumin Placebo P
BFM (kg) 13.15 ± 0.52 12.74 ± 0.60 8.06 ± 0.53 12.04 ± 0.47 11.22 ± 0.43 7.51 ± 0.44 -0.41 ± 0.21 -0.82 ± 0.15 0.245 -4.68 ± 0.37 -3.72 ± 0.29 0.115 0.085*
BFM RA (kg) 0.69 ± 0.04 0.65 ± 0.05 0.45 ± 0.03 0.60 ± 0.03 0.53 ± 0.03 0.43 ± 0.03 -0.04 ± 0.02 -0.07 ± 0.01 0.169 -0.20 ± 0.03 -0.10 ± 0.02 0.007 0.011 *
BFM LA (kg) 0.71 ± 0.04 0.66 ± 0.05 0.44 ± 0.03 0.61 ± 0.03 0.54 ± 0.03 0.42 ± 0.02 -0.05 ± 0.02 -0.07 ± 0.01 0.407 -0.22 ± 0.03 -0.12 ± 0.02 0.004 0.005 *
BFM RL (kg) 2.11 ± 0.07 2.02 ± 0.08 1.56 ± 0.09 1.93 ± 0.06 1.84 ± 0.06 1.48 ± 0.08 -0.09 ± 0.03 -0.09 ± 0.02 0.943 -0.46 ± 0.06 -0.35 ± 0.05 0.192 0.085*
BFM LL (kg) 2.08 ± 0.07 2.01 ± 0.08 1.54 ± 0.09 1.91 ± 0.06 1.83 ± 0.05 1.47 ± 0.08 -0.08 ± 0.03 -0.08 ± 0.02 0.786 -0.47 ± 0.06 -0.36 ± 0.05 0.167 0.231*
BFM Trunk (kg) 6.50 ± 0.29 6.34 ± 0.34 3.38 ± 0.27 5.95 ± 0.28 5.49 ± 0.26 3.08 ± 0.21 -0.16 ± 0.12 -0.47 ± 0.09 0.040 -2.96 ± 0.21 -2.41 ± 0.17 0.043 0.211*
WC (cm) 79.68 ± 0.75 80.33 ± 0.88 68.28 ± 0.82 79.47 ± 0.74 78.30 ± 0.65 66.74 ± 0.62 0.65 ± 0.32 -1.18 ± 0.25 0.001 -12.05 ± 0.79 -11.55 ± 0.6 0.616 0.109*

P (time×group), interaction effect between group and time in repeated measures ANOVA; *P < 0.05, time effect is significant in the repeated measures ANOVA; #P < 0.05, group effect is significant in the repeated measures ANOVA. P values less than 0.05 are bold, indicating that these results are statistically significant

Abbreviations: BFM Body Fat Mass, BFM−RA Body Fat Mass of Right Arm, BFM−LA Body Fat Mass of Left Arm, BFM−RL Body Fat Mass of Right Leg, BFM−LL Body Fat Mass of Left Leg, BFM−Trunk Body Fat Mass of Trunk, WC Waist circumference

Effects of curcumin on gut microbiota composition at species level

After curcumin treatment, β diversity analysis suggested noticeable differences in the composition of the microbial communities between groups while no significant difference in α diversity between groups was observed, as detailed in our previous study [6]. The relative abundances of the top 20 bacteria at the species level were compared in groups (Fig. 1A). Eubacterium rectale, Faecalibacterium prausnitzii, and Bifidobacterium pseudocatenulatum were three dominant members in curcumin group at T2, while Faecalibacterium prausnitzii, Bifidobacterium adolescentis, and Prevotella copri were the top 3 species in placebo group. Linear discriminant analysis effect size (LEfSe) was analyzed, with a total of 14 biomarkers (Fig. 1B). The superior species of the curcumin group were Veillonella dispar, Bifidobacterium pseudocatenulatum, Clostridium sp. CAG:58 and Anaerostipes hadrus at T2, while the representative genera were Blautia sp. CAG:257, Lactonifactor longoviformis, Bacteroides caccae, and Parabacteroides distasonis at T0. The placebo group at T2 was represented by Bifidobacterium adolescentis, Hungatella hathewayi and Ralstonia sp MD27, while characterized by Collinsella aerofaciens, Bacteroides cellulosilyticus, and Actinomyces sp. S6 Spd3 at T0.

Fig. 1.

Fig. 1

Biodiversity analysis between cohorts. A Barplots of microbial relative abundances at species level for curcumin and placebo group; B LEfSe analysis based on species level; C) Species with significant differences between curcumin and placebo groups at T2; D Species with significant differences in placebo group at T0 and T2, E Species with significant differences in curcumin group at T0 and T2; F Changes at species from T0 to T2 with significant differences in curcumin and placebo groups

Higher Bifidobacterium pseudocatenulatum, Eubacterium eligens, Eubacterium sp. CAG:274, Eubacterium sp. CAG:38, and Anaerostipes hadrus were in curcumin group, while lower Eubacterium sp. CAG:180, Bifidobacterium adolescentis and Prevotella copri when compared with placebo group (P < 0.01, Fig. 1C). In placebo group, Bifidobacterium adolescenti, Anaerostipes hadrus, and Veillonella parvula significantly increased at T2 when compared with T0 (P < 0.01, Fig. 1D). In curcumin group, the relative abundance of Bifidobacterium pseudocatenulatu, Eubacterium eligens, Veillonella parvula, Veillonella atypica, and Veillonella dispar significantly increased at T2 when compared with T0, while Escherichia coli, and Alistipes shahii significantly decreased (P < 0.01, Fig. 1E).

The changes from T0 to T2 of species with significant differences in curcumin and placebo groups were shown in Fig. 1F. The increase of Actinomyces oris, Bifidobacterium pseudocatenulatum, Prevotella stercorea, and Eubacterium eligens in curcumin group was greater than those in placebo group, while the increase of Collinsella massiliensis, Bacteroides caccae, and Hungatella hathewayi was lower than that those in placebo group (P < 0.01).

Correlation analysis of body composition biomarkers and gut differential microbes

As shown in Fig. 2A, the relative abundance of Holdemanella biformis was significantly and negatively associated with AMC (P < 0.05). Eubacterium sp. CAG:180 showed a significant negative correlation with SLM and SMM (P < 0.05), while positively correlated with PBF without significant difference. Roseburia intestinalis was significantly and negatively correlated with the weight, FFM and SLM (P < 0.05). Bifidobacterium adolescentis was negatively correlated with HGS, while Bifidobacterium pseudocatenulatum was positively correlated with AC and AMC without statistical significance. The abundance of Eubacterium sp. CAG:180 (P < 0.05) and Holdemanella biformis in curcumin group was lower than them in placebo group at T2, while Roseburia intestinalis in curcumin group was higher than that in placebo group (Fig. 2B-D).

Fig. 2.

Fig. 2

Correlation analysis of body composition biomarkers and gut differential microbes. A Heat map showing the correlation between species-level gut differential microorganisms and body composition biomarkers; B-D Relative abundance of representative species including Holdemanella biformis, Eubacterium sp. CAG:180 and Roseburia intestinalis at T2. Statistical significance is denoted by *, **, and *** for P < 0.05, P < 0.01, and P < 0.001, respectively

Gut microbiome biomarker of PBF and SMI at high altitude

Further analysis based on a random forest approach was conducted to explore the gut flora characteristics of the 20 subjects with the highest SMI or lowest PBF (Fig. 3A-B). The top 3 species average rankings for the highest SMI were Eubacterium sp. CAG:274, Roseburia inulinivorans, and Bifidobacterium pseudocatenulatum (Fig. 3C-E). The abundance of Bifidobacterium pseudocatenulatum (P < 0.001) and Eubacterium sp. CAG:274 (P < 0.01) and Roseburia inulinivorans at T2 in curcumin group was higher than them in placebo group. The top 3 species average rankings for the lowest PBF were Lachnospira pectinoschiza, Clostridium leptum, and Eubacterium sp. CAG:274 (Fig. 3E-G). The abundance of Eubacterium sp. CAG:274 (P < 0.01), Lachnospira pectinoschiza, and Clostridium leptum at T2 in curcumin group was greater than them in placebo group. Additionally, the abundance of Eubacterium eligens in curcumin group was significantly higher than that in placebo group (Fig. 3H, P < 0.01).

Fig. 3.

Fig. 3

Gut microbiome biomarker of SMI and PBF at high altitude. Ranking the importance of species to prediction high SMI (A) or low PBF (B); the x-axis represents the importance metric, and the higher the value on the x-axis, the greater importance of the species. Details on parameter settings are shown in the Supplementary Method. C-H Relative abundance changes from T0 to T2 of representative species in curcumin and placebo group. Statistical significance is denoted by *, **, and *** for P < 0.05, P < 0.01, and P < 0.001, respectively

Discussion

In this randomized controlled trial, curcumin supplementation showed differential effects on body composition and muscle function among 102 Han male participants exposed to 3,000 m plateau. Curcumin significantly reduced PBF and attenuated the reduction of upper-limb FFM and AMC, while SLM, SMM and FFM increased in both groups with a greater but non-significant increase observed in the curcumin group. An increasing trend of HGS from T1 to T2 was observed exclusively in the curcumin group although without significant difference. These results may be associated that curcumin modulated the microbiome compositions by increasing the abundance of bacteria that produced short chain fatty acids (SCFAs) especially for butyrate, while decreasing the abundance of opportunistic pathogen. Curcumin supplementation significantly increased the abundance of butyrate producing bacteria Clostridium leptum, Lachnospira pectinoschiza, Eubacterium sp. CAG:274, and the probiotic Bifidobacterium pseudocatenulatum. In a subgroup analysis comparing the 20 participants with the highest SMI and the 20 participants with the lowest PBF in the entire cohort, random forest feature importance analysis identified these four species as key microbial biomarkers that distinguish the favorable metabolic phenotype with high SMI and low PBF. These findings suggested that there was an association between body composition and gut microbiome modulating by curcumin, and their causal association remains to be further verified.

Curcumin can effectively activate the PI3K/Akt/mTOR pathway leading to phosphorylation of p70S6K, which promotes protein synthesis and inhibits degradation in muscle tissue [13]. Previous studies have reported that curcumin supplementation might help ameliorate skeletal muscle atrophy and enhance the physical performance of the personnel at high-altitude regions [9]. In the present study, muscle mass related indexes including SLM, SMM and FMM were increased in both groups after high-altitude acclimatization. This may be attributable to the fact that all subjects were young males in good physical performance and continuously engaged in low-intensity aerobic running exercises at high altitude. Notably, changes in FMM were manifested by an increase in lower limb FMM and a decrease in trunk and upper limb FMM in both groups, while participants in the curcumin group showed greater gain in lower limb FFM and less loss of upper limb and trunk FFM. A clinical research trial reported that metabolic syndrome older adults with strength training plus curcumin supplementation stood out as the most beneficial, positively improving all metabolic syndrome-related variables especially with the greatest fat mass reductions and muscle mass gain [17]. Based on these results, we hypothesize that curcumin supplementation combined with exercise may have a synergistic effect on increasing muscle mass at high altitude. However, it is important to explicitly note that this interpretation is derived from the alignment between intervention characteristics and observed phenotypic changes, and the underlying molecular and physiological mechanisms remain to be directly verified in future targeted studies.

This study also confirmed that curcumin decreased fat mass at high altitude. PBF with a greater decrease in curcumin group were observed when compared with placebo group after a 6-week high altitude acclimatization. The reduction of trunk and upper limb of BFM in curcumin group was significantly greater than that in placebo group. Experimental evidence suggested that curcumin exhibited beneficial effects on obesity by attenuating adipocyte hypertrophy and reducing adipose tissue accumulation, and mediated gut microbiota-derived metabolites such as SCFAs and succinate, which in turn lead to the activation of thermogenic genes [18]. A pilot study found that curcumin supplementation 1500 mg daily for 13 weeks may alleviate some gastrointestinal symptoms and reduced BMI and neck circumference in women with severe obesity [19].

Accumulating evidence supports regulatory role of gut microbiota in skeletal muscle mass and physical functioning, defined as the gut-muscle axis. In the present study, Eubacterium sp. CAG:274, Roseburia inulinivorans, and Bifidobacterium pseudocatenulatum are identified as biomarker of subjects with high SMI, while Lachnospira pectinoschiza, Clostridium leptum, and Eubacterium sp. CAG:274 are biomarker of participants with low PBF, especially for Eubacterium sp. CAG:274, Roseburia inulinivorans, Lachnospira pectinoschiza, Clostridium leptum are butyrate producers. Microbiome-derived butyrate has several distinct roles for the intestinal epithelium, being an energy source for colonocytes, regulating mucosal homeostasis and exerting anti-inflammatory effects on the intestinal environment [20]. The relative abundance of butyrate-producing bacteria was positively associated with healthier muscle mass, strength and function [21]. Moreover, Han et al. identified the fecal butyrate level was robustly measured to be higher in normal elders when comparing with low muscle mass elders and correlates positively with the SMI [22].

The genera Eubacterium and Roseburia were reported that significantly less abundant in patients with sarcopenia [23, 24], and positive correlation was identified between Eubacterium and Roseburia and SMI, indicating that they were less abundant in individuals with smaller muscle mass. In present study, the abundance of Eubacterium sp. CAG:180 and Roseburia intestinalis significantly and negatively correlated with SLM, while Roseburia inulinivorans and Eubacterium sp. CAG:274, belonging to the same genus as them, were enriched among participants with high level of SMI. Furthermore, Eubacterium sp. CAG:274 was observed to be highly enriched in subjects with low PBF. Eubacterium sp. CAG:180 and Eubacterium sp. CAG:274 are attributed to the genus of Eubacterium, phylum of Firmicutes. Curcumin supplementation significantly increased the abundance of Eubacterium sp. CAG:274, while decreased Eubacterium sp. CAG:180 at high altitudes. Furthermore, Eubacterium eligens was significantly more abundant in the curcumin group than in the placebo group, and it has also been recognized as a biomarker of subjects with high SMI. To the best of our knowledge, this is the first study to report on the effect of Eubacterium on SMI and PBF at species level, in particular to conduct comparisons from the dimensions of high altitude and curcumin supplementation.

Curcumin supplementation increased the abundance of Roseburia intestinalis and Roseburia inulinivorans at high altitudes, that was consistent with our pervious study found Roseburia was the superior genera of the curcumin group after high-altitude acclimatization [6]. Roseburia intestinalis is one of the most abundant and important butyrate-producing human gut anaerobic bacteria, with potentially high value as a next-generation probiotic to promote host intestinal health [25]. Current research on Roseburia intestinalis has focused in the direction of inflammatory bowel disease and has not been reported in relation to muscle mass. A single study was published that grip strength of age range 90 years and above long-lived adults was positively correlated with the abundance of Roseburia intestinalis [26]. This finding appears to be at odds with our results that may be attributed to the different participants and altitude ranges selected by researchers. There are marked differences in the intestinal flora of the elderly and young populations, with significantly lower abundance of beneficial bacteria in the elderly than in healthy adults, which may make it easier to highlight the health effects of Roseburia intestinalis. The differential results further emphasized the influence of geographical locations and research subjects on gut microbiota composition. Roseburia inulinivorans, mainly producing butyric and propionic acid, is the only propionic acid-producing bacterium in genus of Roseburia. Yuzefpolskaya et al. reported that the abundance of Roseburia intestinalis in gut was associated with increased ratio of serum creatinine to cystatin C [27], which has been termed sarcopenia index and validated as a readily available biomarker of skeletal muscle mass in several populations [28–30]. These founding are consistent with the results of the present study. In addition, Lachnospira pectinoschiza and Clostridium leptum, butyrate producing bacteria, was found to enrich in participants with low PBF and known to ameliorate intestinal inflammatory or obesity [31–34]. In the present study, the abundance of Bifidobacterium increased in both the curcumin and placebo groups, however, their dominant species differed. The curcumin group was dominated by Bifidobacterium pseudocatenulatum, while the placebo group showed Bifidobacterium adolescentis as the superior species. In particularly, Bifidobacterium pseudocatenulatum was identified as a biomarker of subjects with high SMI. Our findings were consistent with previous study that found Bifidobacterium pseudocatenulatum and Bifidobacterium adolescentis were decreased in participants of sarcopenia and further observed that Bifidobacterium pseudocatenulatum was positively linked to calf circumference, which may serve as precise diagnostic markers for sarcopenia [35]. Furthermore, some evidence showed that the higher abundance of Bifidobacterium pseudocatenulatum was significantly associated with lower body weight gain and fat mass [36, 37]. Administration of live Bifidobacterium pseudocatenulatum decreased fat deposition and enhances colonic secondary bile acid biosynthesis in a high-fat diet-fed mice model [38].

In this study, curcumin supplementation remarkably enriched the abundance of Veillonella, including Veillonella parvula, Veillonella atypica, Veillonella dispar, Veillonella sp T11011 6, Veillonella infantium, and Veillonella rogosae after acclimatization to high altitude. Consistent with previous reports that observed Veillonella was more abundant in the high-altitude Han population when compared with the low-altitude Han population [39, 40]. Veillonella is a gram-negative anaerobic bacterium that accumulates in low-pressure and hypoxic environments to help the host adapt to high altitude. Genera of Veillonella utilize lactate as their sole carbon source, which contributes to removing lactate accumulated after exercise and produces propionate via the methylmalonyl-CoA pathway [41]. Harvard researchers observed an increase Veillonella relative abundance in marathon runner’s post-marathon and inoculated it into mice that significantly increased their exhaustive treadmill runtime [42]. Unfortunately, this study only tested HGS of subjects without a systematic and standardized physical performance assessment. Compared with the results of the last HGS value before going to the high plateau, the average HGS of the curcumin group increased by 0.63 kg after 6-week high altitude accumulation, while that of the placebo group decreased by 0.27 kg.

Prevotella copri is the most prevalent member within Prevotella genus and some studies suggest that Prevotella copri increases under hypoxic conditions at high altitudes [43]. In this study, Prevotella copri decreased in either curcumin or placebo group after acclimatizing to high altitude, with a greater decrease in the placebo group. This discrepancy may arise from differences in geographical locations and dietary habits of the study populations. A high-fat diet has been reported to decrease the abundance of Prevotella copri, while a high-fiber diet promotes the growth of it and its ability to break down carbohydrates [44]. This study was conducted during winter when vegetables and fruits were scarce in the plateau region, which may have led to insufficient dietary fiber intake among the study participants. Furthermore, it does not mean that the higher the abundance of Prevotella, the more beneficial it is for the host to adapt to the high-altitude environment. Our previous study found higher abundance of Prevotella has been shown to be involved in gastrointestinal symptoms of acute mountain sickness [6]. Prevotella enerotype is reported that associated with the host genotype of rheumatoid arthritis before disease onset, enhances disease susceptibility, and exacerbates disease severity of rheumatoid arthritis and colonic inflammation [45, 46]. Rheumatoid arthritis is the second highly prevalent chronic disease in Tibet. It is highly speculative that the high prevalence of rheumatoid arthritis in the Tibetan population could be associated with their high abundance of Prevotella [47, 48]. The role of Prevotella copri for host acclimatization to high-altitude environments is still controversial, and further studies are required to validate causation.

Strengths and limitations

This study possesses several notable strengths. This might be the first randomized clinical trial to investigate the effects of curcumin on body composition and gut microbiota for high altitude acclimation in the male Han population. In addition, the cohort, which consists of male Han adults from the plains rapidly enter the plateau, is unique due to its comprehensive demographic, physiological, and metagenomic data. These valuable data provide some scientific and public health insights for other highlanders as well.

Nonetheless, several limitations should be acknowledged. Firstly, this study was with a small sample size and focused on young males. Although the samples partially reflected the demographic characteristics of travelers or workers at high altitude, predominantly young adults with a lower proportion of older individuals, which might limit the general applicability of findings to broader populations. Secondly, body composition was assessed via BIA, a method widely adopted for evaluating body water, muscle mass, and fat mass due to its convenience and low cost. However, BIA is not considered the gold standard for body composition analysis when compared to dual-energy X-ray absorptiometry (DXA) and its accuracy can be influenced by factors such as hydration status and body position. Similarly, participants were subject to standardized, centralized dietary and exercise management throughout the intervention period, but not employ gold-standard methods like dietary weighing or wearable device monitoring to quantitatively assess diet and exercise due to limited funding. If future research funding permits, we plan to compare the consistency of measurements obtained by gold-standard methods to validate the reliability of the findings reported in this paper. Thirdly, this study only conducted association analysis of gut microbiota composition, therefore the causal relationship between microbiota changes and body composition improvements cannot be determined. Future research will adopt approaches including germ-free mouse microbiota transplantation, integrated metagenomic and metabolomic analysis, and targeted intervention of specific pathways, to further verify the potential mediating role of gut microbiota in the effect of curcumin on improving high-altitude body composition, and to clarify its causal association and specific molecular mechanisms.

Conclusion

Significant changes of body composition and gut microbiota were observed during high-altitude exposure. SLM, SMM and FFM were increased in both groups at high altitudes, but that the curcumin group exhibited greater increases although without significant difference. Specifically, curcumin supplementation increased low-limbs FFM gain, attenuated the upper-limbs and trunk FFM reduction, and significantly decreased PBF in acclimatization to high altitude. Meanwhile, curcumin supplementation increased the abundance of butyrate producers including Clostridium leptum, Lachnospira pectinoschiza, Eubacterium sp. CAG:274, and probiotic Bifidobacterium pseudocatenulatum, which were considered as biomarkers of participants with high SMI and low PBF. These findings suggested that a significant correlation between changes in gut microbiota composition and improvements in body composition after curcumin intervention at high altitudes, and their causal association remains to be further verified.

Supplementary Information

Supplementary Material 1. (196.9KB, doc)
Supplementary Material 2. (106.3KB, docx)

Acknowledgements

The authors gratefully acknowledge all the people that have made this study.

Authors’ contributions

Ning Lin: conceptualization, supervision, and draft revision. Jilei Hu: writing the original draft. Ning Lin, Jilei Hu, Chunxiu Xiao, and Die Fan: trial execution. Jiaojiao Shi and Chao Kang: data curation. Jie Liu: blood testing. Yunming Li and Lirong Shen: methodology and statistical analysis.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by grants from the Natural Science Foundation of Sichuan Province (No. 2022NSFSC1422 and 25NSFSC1709), and the Open Research Project of the Provincial Key Laboratory of Prevention and Translational Medicine for Major Chronic Diseases at Soochow University (KJS2525).

Data availability

All data generated or analyzed during this study are included in this published article. The raw data are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

The study protocol was reviewed and approved by the ethics committee of The General Hospital of the Western Theater Command (No. 2021EC3-45) and adhered to the principles of the Declaration of Helsinki. All the participants have written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Dünnwald T, Gatterer H, Faulhaber M, Arvandi M, Schobersberger W. Body Composition and Body Weight Changes at Different Altitude Levels: A Systematic Review and Meta-Analysis. Front Physiol. 2019;10:430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kayser B, Verges S. Hypoxia, energy balance and obesity: from pathophysiological mechanisms to new treatment strategies. Obes Rev. 2013;14:579–92. [DOI] [PubMed] [Google Scholar]
  • 3.Zhou S, Dong H, Huang P, Li Y, Zhong Z, Xiao H, Xie J, Wu Y, Li P. Changes in body composition during acute exposure to high altitude is related to acute mountain sickness. Travel Med Infect Dis. 2025;64:102815. [DOI] [PubMed] [Google Scholar]
  • 4.Li W, Li X, Huang T, Chen Y, Zhang H, Dai H, Wen Y. Normative reference data for body composition in healthy indigenous populations on the Qinghai-Tibet Plateau. Front Public Health. 2022;10:986720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ticinesi A, Lauretani F, Milani C, Nouvenne A, Tana C, Del Rio D, Maggio M, Ventura M, Meschi T. Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia. Is There a Gut-Muscle Axis? Nutrients; 2017. p. 9. [DOI] [PMC free article] [PubMed]
  • 6.Hu J, Lang H, Fan D, Wen T, Shi J, Xiao C, Li Y, Kang C, Shi P, Shen L, Lin N. Curcumin supplementation accelerates high-altitude acclimatization, prevents polycythemia and modulates gut microbiota in male Han population: a randomized controlled trial. Front Nutr. 2025;12:1572376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fernández-Landa J, Calleja-González J, León-Guereño P, Caballero-García A, Córdova A, Mielgo-Ayuso J. Effect of the Combination of Creatine Monohydrate Plus HMB Supplementation on Sports Performance, Body Composition, Markers of Muscle Damage and Hormone Status: A Systematic Review. Nutrients. 2019;11:10. [DOI] [PMC free article] [PubMed]
  • 8.Bideshki MV, Behzadi M, Jamali M, Jamilian P, Zarezadeh M, Gargari BP. Ergogenic Benefits of β-Hydroxy-β-Methyl Butyrate (HMB) Supplementation on Body Composition and Muscle Strength: An Umbrella Review of Meta-Analyses. J Cachexia Sarcopenia Muscle. 2025;16:e13671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rathor R, Suryakumar G, Singh SN. Diet and redox state in maintaining skeletal muscle health and performance at high altitude. Free Radic Biol Med. 2021;174:305–20. [DOI] [PubMed] [Google Scholar]
  • 10.Agrawal A, Rathor R, Kumar R, Suryakumar G, Singh SN, Kumar B. Redox modification of ryanodine receptor contributes to impaired Ca(2+) homeostasis and exacerbates muscle atrophy under high altitude. Free Radic Biol Med. 2020;160:643–56. [DOI] [PubMed] [Google Scholar]
  • 11.Liu Q, Wang C, Guo X, Du Q, Keshavarzi M. Curcumin and its nano-formulations combined with exercise: From molecular mechanisms to clinic. Cell Biochem Funct. 2024;42:e4061. [DOI] [PubMed] [Google Scholar]
  • 12.Nosrati-Oskouie M, Aghili-Moghaddam NS, Tavakoli-Rouzbehani OM, Jamialahmadi T, Johnston TP, Sahebkar A. Curcumin: A dietary phytochemical for boosting exercise performance and recovery. Food Sci Nutr. 2022;10:3531–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Koh YC, Hsu HW, Ho PY, Lin WS, Hsu KY, Majeed A, Ho CT, Pan MH. Feruloylacetone and Its Analog Demethoxyferuloylacetone Mitigate Obesity-Related Muscle Atrophy and Insulin Resistance in Mice. J Agric Food Chem. 2025;73:1231–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mohsenpour MA, Mohammadi F, Sohrabi Z, Niakousari M, Jeddi M, Eftekhari MH. Mental health and health-related quality of life response to curcumin-probiotic drink powder co-supplementation in adults with overweight/obesity and metabolic syndrome: a four-arm randomised, double-blind, placebo-controlled, clinical trial. Br J Nutr. 2025;133:1320–30. [DOI] [PubMed] [Google Scholar]
  • 15.Chaudhary P, Sharma YK, Sharma S, Singh SN, Suryakumar G. High altitude mediated skeletal muscle atrophy: Protective role of curcumin. Biochimie. 2019;156:138–47. [DOI] [PubMed] [Google Scholar]
  • 16.Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, et al. Bioelectrical impedance analysis–part I: review of principles and methods. Clin Nutr. 2004;23:1226–43. [DOI] [PubMed] [Google Scholar]
  • 17.Juesas A, Saez-Berlanga A, Babiloni-Lopez C, Martin EG, Garrigues-Pelufo L, Ferri-Caruana A, Gene-Morales J, Martin-Rivera F, Chulvi-Medrano I, Jiménez-Martínez P, et al. Effects of Accentuated Eccentric and Maximal Strength High-Resistance Training Programs with or Without a Curcumin-Based Formulation Supplement on Body Composition, Blood Pressure, and Metabolic Parameters in Older Adults. Diseases. 2025;13. [DOI] [PMC free article] [PubMed]
  • 18.Yang C, Du Y, Zhao T, Zhao L, Liu L, Liu L, Yang X. Consumption of dietary turmeric promotes fat browning and thermogenesis in association with gut microbiota regulation in high-fat diet-fed mice. Food Funct. 2024;15:8153–67. [DOI] [PubMed] [Google Scholar]
  • 19.Kattah FM, Figueiredo N, Bezerra KK, Oliveira ES, Melo CC, Lima GB, Cavalcante JPR, Benetti B, Lima GC, Mota JF, Corgosinho FC. Curcumin Supplementation Improves Gastrointestinal Symptoms in Women with Severe Obesity: A Double-Blind, Randomized, Placebo-Controlled Trial-A Pilot Study. Nutrients 2025, 17. [DOI] [PMC free article] [PubMed]
  • 20.Barger K, Langsetmo L, Orwoll ES, Lustgarten MS. Investigation of the Diet-Gut-Muscle Axis in the Osteoporotic Fractures in Men Study. J Nutr Health Aging. 2020;24:445–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Davis JA, Collier F, Mohebbi M, Pasco JA, Shivappa N, Hébert JR, Jacka FN, Loughman A. The associations of butyrate-producing bacteria of the gut microbiome with diet quality and muscle health. Gut Microbiome (Camb). 2021;2:e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Han DS, Wu WK, Liu PY, Yang YT, Hsu HC, Kuo CH, Wu MS, Wang TG. Differences in the gut microbiome and reduced fecal butyrate in elders with low skeletal muscle mass. Clin Nutr. 2022;41:1491–500. [DOI] [PubMed] [Google Scholar]
  • 23.Kang L, Li P, Wang D, Wang T, Hao D, Qu X. Alterations in intestinal microbiota diversity, composition, and function in patients with sarcopenia. Sci Rep. 2021;11:4628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Karimianghadim R, Satokari R, Yeo S, Arkkila P, Kao D, Pakpour S. Prolonged effect of antibiotic therapy on the gut microbiota composition, functionality, and antibiotic resistance genes’ profiles in healthy stool donors. Front Microbiol. 2025;16:1589704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mukhopadhya I, Martin JC, Shaw S, Gutierrez-Torrejon M, Boteva N, McKinley AJ, Gratz SW, Scott KP. Novel insights into carbohydrate utilisation, antimicrobial resistance, and sporulation potential in Roseburia intestinalis isolates across diverse geographical locations. Gut Microbes. 2025;17:1. [DOI] [PMC free article] [PubMed]
  • 26.Deng L, Xu J, Xue Q, Wei Y, Wang J. Healthy Ageing and Gut Microbiota: A Study on Longevity in Adults. Microorganisms. 2025;13(7):1657. [DOI] [PMC free article] [PubMed]
  • 27.Yuzefpolskaya M, Bohn B, Ladanyi A, Pinsino A, Braghieri L, Carey MR, Clerkin K, Sayer GT, Latif F, Koji T, et al. Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients. J Heart Lung Transpl. 2024;43:1395–408. [DOI] [PubMed] [Google Scholar]
  • 28.Zheng C, Wang E, Li JS, Xie K, Luo C, Ge QY, Hu LW, Shen Y. Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer. BMC Geriatr. 2022;22:207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Tang T, Xie L, Hu S, Tan L, Lei X, Luo X, Yang L, Yang M. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2022;13:1800–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wang S, Xie L, Xu J, Hu Y, Wu Y, Lin Z, Pan S. Predictive value of serum creatinine/cystatin C in neurocritically ill patients. Brain Behav. 2019;9:e01462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Satokari R, Fuentes S, Mattila E, Jalanka J, de Vos WM, Arkkila P. Fecal transplantation treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up. Case Rep Med. 2014;2014:913867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Li T, Liang M, Luo J, Peng X. Metabolites of Clostridium leptum fermenting flaxseed polysaccharide alleviate obesity in rats. Int J Biol Macromol. 2024;264:129907. [DOI] [PubMed] [Google Scholar]
  • 33.Bo TB, Zhang XY, Wen J, Deng K, Qin XW, Wang DH. The microbiota-gut-brain interaction in regulating host metabolic adaptation to cold in male Brandt’s voles (Lasiopodomys brandtii). Isme j. 2019;13:3037–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Han Y, Liu X, Jia Q, Xu J, Shi J, Li X, Xie G, Zhao X, He K. Longitudinal multi-omics analysis uncovers the altered landscape of gut microbiota and plasma metabolome in response to high altitude. Microbiome. 2024;12:70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.He Y, Cui W, Fang T, Zhang Z, Zeng M. Metabolites of the gut microbiota may serve as precise diagnostic markers for sarcopenia in the elderly. Front Microbiol. 2023;14:1301805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Fernández-Murga ML, Olivares M, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reverses the adverse effects of diet-induced obesity through the gut-bone axis. Bone. 2020;141:115580. [DOI] [PubMed] [Google Scholar]
  • 37.de la Ruiz A, Langa S, Peirotén Á, Curiel JA, Fernández-González R, Maroto M, Arqués J, Gutiérrez-Adán A, Landete JM. Fermented Lignan-Enriched Soy Beverage Ameliorates the Metabolic Effects of a High-Fat Diet on Female Mice. J Agric Food Chem. 2025;73:5194–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zha A, Qi M, Deng Y, Li H, Wang N, Wang C, Liao S, Wan D, Xiong X, Liao P, et al. Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis. Imeta. 2024;3:e261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Li J, Suonan L, Lin J, Zhaxi J, Gong M, Li J, Langjie D, Zhu L, Shique Q, Chen C. Comparative analysis of oral saliva microbiomes and metabolites in Han population at different altitudes. Front Microbiol. 2024;15:1468365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhou Q, Chen Y, Liu G, Qiao P, Tang C. A preliminary study of the salivary microbiota of young male subjects before, during, and after acute high-altitude exposure. PeerJ. 2023;11:e15537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ng SK, Hamilton IR. Carbon dioxide fixation by Veillonella parvula M 4 and its relation to propionic acid formation. Can J Microbiol. 1973;19:715–23. [DOI] [PubMed] [Google Scholar]
  • 42.Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham LD, Wibowo MC, Wurth RC, Punthambaker S, Tierney BT, et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019;25:1104–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Peng L-L, Qi F-L, Tan K, Xiao W. The altitudinal patterns of global human gut microbial diversity. BMC Microbiol. 2025;1:1–12. [DOI] [PMC free article] [PubMed]
  • 44.Kushugulova A, Forslund SK, Costea PI, Kozhakhmetov S, Khassenbekova Z, Urazova M, Nurgozhin T, Zhumadilov Z, Benberin V, Driessen M, et al. Metagenomic analysis of gut microbial communities from a Central Asian population. BMJ Open. 2018;8:e021682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Alpizar-Rodriguez D, Lesker TR, Gronow A, Gilbert B, Raemy E, Lamacchia C, Gabay C, Finckh A, Strowig T. Prevotella copri in individuals at risk for rheumatoid arthritis. Ann Rheum Dis. 2019;78:590–3. [DOI] [PubMed] [Google Scholar]
  • 46.Wells PM, Adebayo AS, Bowyer RCE, Freidin MB, Finckh A, Strowig T, Lesker TR, Alpizar-Rodriguez D, Gilbert B, Kirkham B, et al. Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study. Lancet Rheumatol. 2020;2:e418–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Deng R, Labasangzhu, Zhaxideji, Wang G, Hong P, Li J, Li Q, Wan Y, Xiong H. Illness prevalence rate in Tibet, China: data from the 2018 National Health Service Survey. BMC Public Health. 2020;20:955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zhang Q, Liu Q, Lin C, Baima Y, Li H, Gong H, Lin J. The prevalence of rheumatoid arthritis in middle-aged and elderly people living in Naqu City, Tibet, Autonomous Region of China. J Orthop Surg Res. 2020;15:338. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1. (196.9KB, doc)
Supplementary Material 2. (106.3KB, docx)

Data Availability Statement

All data generated or analyzed during this study are included in this published article. The raw data are available from the corresponding author on reasonable request.


Articles from Nutrition Journal are provided here courtesy of BMC

RESOURCES